| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9153796 | American Heart Journal | 2005 | 6 Pages |
Abstract
Bivalirudin, as a single antithrombotic agent during PCI and VBT with β emitters, may be used safely, but its use in the setting of PCI and gamma radiation may not be acceptable due to an increased incidence of acute procedural intracoronary thrombosis.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Pramod MD, Roswitha MD, Rebecca MS, Seung-Woon MD, Edouard MD, Ellen E. MS, Daniel MPH, Lowell F. MD, Augusto D. MD, Kenneth M. MD, PhD, Ron MD,